These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8719526)

  • 1. Urgent need for effective vaccine against Salmonella paratyphi A, B and C.
    Arya SC; Sharma KB
    Vaccine; 1995 Dec; 13(17):1727-8. PubMed ID: 8719526
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
    Pakkanen SH; Kantele JM; Kantele A
    Vaccine; 2012 Sep; 30(42):6047-53. PubMed ID: 22858557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-reactive immune response induced by the Vi capsular polysaccharide typhoid vaccine against Salmonella Paratyphi strains.
    Pakkanen SH; Kantele JM; Kantele A
    Scand J Immunol; 2014 Mar; 79(3):222-9. PubMed ID: 24383914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant SpaO and H1a as immunogens for protection of mice from lethal infection with Salmonella paratyphi A: implications for rational design of typhoid fever vaccines.
    Ruan P; Xia XP; Sun D; Ojcius DM; Mao YF; Yue WY; Yan J
    Vaccine; 2008 Dec; 26(51):6639-44. PubMed ID: 18834913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuated
    Liu Q; Li P; Luo H; Curtiss R; Kong Q
    Virulence; 2019 Dec; 10(1):82-96. PubMed ID: 31874075
    [No Abstract]   [Full Text] [Related]  

  • 6. Construction of an attenuated Salmonella enterica serovar Paratyphi A vaccine strain harboring defined mutations in htrA and yncD.
    Zhu C; Xiong K; Chen Z; Hu X; Li J; Wang Y; Rao X; Cong Y
    Microbiol Immunol; 2015 Aug; 59(8):443-51. PubMed ID: 26084199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B.
    Levine MM; Ferreccio C; Black RE; Lagos R; San Martin O; Blackwelder WC
    Clin Infect Dis; 2007 Jul; 45 Suppl 1():S24-8. PubMed ID: 17582564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and protective efficacy of a Salmonella pathogenicity island 2 (SPI2) mutant of Salmonella Paratyphi A.
    Yin J; Cheng Z; Wu Y; He Q; Zhang J; Yang Z; Ding S; Li J; Guo D
    Microb Pathog; 2019 Dec; 137():103795. PubMed ID: 31610219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-emergence of Salmonella paratyphi A: a shift in immunity?
    Padmapriya V; Kenneth J; Amarnath SK
    Natl Med J India; 2003; 16(1):47-8. PubMed ID: 12715960
    [No Abstract]   [Full Text] [Related]  

  • 10. Status of paratyphoid fever vaccine research and development.
    Martin LB; Simon R; MacLennan CA; Tennant SM; Sahastrabuddhe S; Khan MI
    Vaccine; 2016 Jun; 34(26):2900-2902. PubMed ID: 27083427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Concern: Cell-Associated Flagella Enhance the Protection Conferred by Mucosally-Administered Attenuated Salmonella Paratyphi A Vaccines.
    PLOS Neglected Tropical Diseases Editors
    PLoS Negl Trop Dis; 2024 May; 18(5):e0012160. PubMed ID: 38709719
    [No Abstract]   [Full Text] [Related]  

  • 12. [The anti-Salmonella paratyphi B vaccination].
    Dimache G; Vlădoianu IR; Dimache V; Popescu P; Antonescu O; Mitrea D
    Arch Roum Pathol Exp Microbiol; 1970 Sep; 29(3):477-86. PubMed ID: 4999244
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunochemical examination of typhoid and paratyphoid vaccines prepared from envelope and O antigens (author's transl)].
    Hatunceva NV; Mironova MV; Ryapolova RG
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):135-41. PubMed ID: 4216248
    [No Abstract]   [Full Text] [Related]  

  • 14. Reactogenicity and immunogenicity of live attenuated Salmonella enterica serovar Paratyphi A enteric fever vaccine candidates.
    Roland KL; Tinge SA; Kochi SK; Thomas LJ; Killeen KP
    Vaccine; 2010 May; 28(21):3679-87. PubMed ID: 20338215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing rates of Salmonella Paratyphi A and the current status of its vaccine development.
    Sahastrabuddhe S; Carbis R; Wierzba TF; Ochiai RL
    Expert Rev Vaccines; 2013 Sep; 12(9):1021-31. PubMed ID: 24053396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and immunogenicity evaluation of Salmonella enterica serovar Paratyphi A O-specific polysaccharide conjugated to diphtheria toxoid.
    Ali A; An SJ; Cui C; Haque A; Carbis R
    Hum Vaccin Immunother; 2014; 10(6):1494-8. PubMed ID: 24603090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: typhoid fever vaccines: systematic review and meta-analysis of randomised clinical trials.
    Arya SC; Agarwal N
    Vaccine; 2008 Jan; 26(3):291. PubMed ID: 18082292
    [No Abstract]   [Full Text] [Related]  

  • 18. O:2-CRM(197) conjugates against Salmonella Paratyphi A.
    Micoli F; Rondini S; Gavini M; Lanzilao L; Medaglini D; Saul A; Martin LB
    PLoS One; 2012; 7(11):e47039. PubMed ID: 23144798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving Our Understanding of
    Higginson EE; Ramachandran G; Hazen TH; Kania DA; Rasko DA; Pasetti MF; Levine MM; Tennant SM
    mSphere; 2018 Nov; 3(6):. PubMed ID: 30487152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The experimental foundation underlying several problems in the enteral method of vaccination. IV. The possibility of using antigen complexes from paratyphoid A bacteria as components of enteral vaccines].
    Mironova MV; Khatuntseva NV; Riapolova RG
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Oct; 50(10):44-7. PubMed ID: 4207096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.